Expression of interferon-stimulated genes in insulitic pancreatic islets of patients recently diagnosed with type 1 diabetes

Diabetes

Volumn 65, Issue 10, 2016, Pages 3104-3110

  Lundberg, Marcus ^a   Krogvold, Lars ^b,c   Kuric, Enida ^a   Dahl JØrgensen, Knut ^b,c   Skog, Oskar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA E ANTIGEN; INTERFERON; STAT1 PROTEIN; TOLL LIKE RECEPTOR 3; 2',5' OLIGOADENYLATE SYNTHETASE; GBP1 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; HLA ANTIGEN CLASS 1; HLA-F ANTIGENS; IFI6 PROTEIN, HUMAN; MESSENGER RNA; MITOCHONDRIAL PROTEIN; OAS1 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LASER CAPTURE MICRODISSECTION; ORGAN DONOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS DETECTION; FEMALE; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MALE; METABOLISM; MIDDLE AGED; PANCREAS ISLET; PHYSIOLOGY; YOUNG ADULT;

2',5'-OLIGOADENYLATE SYNTHETASE; ADULT; CHEMOKINE CXCL10; DIABETES MELLITUS, TYPE 1; FEMALE; GTP-BINDING PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, INNATE; INTERFERONS; ISLETS OF LANGERHANS; LASER CAPTURE MICRODISSECTION; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 3; YOUNG ADULT;

EID: 84989204609     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0616     Document Type: Article

References (34)

1. Skog O, Korsgren S, Melhus A, Korsgren O. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease. Curr Opin Endocrinol Diabetes Obes 2013;20:118-123
2. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and betacell loss in type 1 diabetes. Nat Rev Endocrinol 2009;5:219-226
3. von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: Making the barren field fertile? Nat Rev Microbiol 2003;1:151-157
4. Chehadeh W, Kerr-Conte J, Pattou F, et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 2000;74:10153-10164
5. Gallagher GR, Brehm MA, Finberg RW, et al. Viral infection of engrafted human islets leads to diabetes. Diabetes 2015;64:1358-1369
6. Morgan NG, Richardson SJ. Enteroviruses as causative agents in type 1 diabetes: Loose ends or lost cause? Trends Endocrinol Metab 2014;25:611-619
7. Ylipaasto P, Kutlu B, Rasilainen S, et al. Global profiling of coxsackievirusand cytokine-induced gene expression in human pancreatic islets. Diabetologia 2005;48:1510-1522
8. Lind K, Richardson SJ, Leete P, Morgan NG, Korsgren O, Flodström-Tullberg M. Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets. J Virol 2013;87:7646-7654
9. Eizirik DL, Sammeth M, Bouckenooghe T, et al. The human pancreatic islet transcriptome: Expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 2012;8:e1002552
10. Foulis AK, Farquharson MA, Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1987;2:1423-1427
11. Dotta F, Censini S, van Halteren AG, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007;104:5115-5120
12. Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK. Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 2011;33:9-21
13. Roep BO, Kleijwegt FS, van Halteren AG, et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol 2010;159:338-343
14. Tanaka S, Nishida Y, Aida K, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: A mechanism of accelerated b-cell failure in fulminant type 1 diabetes. Diabetes 2009;58:2285-2291
15. Somoza N, Vargas F, Roura-Mir C, et al. Pancreas in recent onset insulindependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 1994;153:1360-1377
16. Huang X, Yuang J, Goddard A, et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 1995;44:658-664
17. Planas R, Carrillo J, Sanchez A, et al. Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes. Clin Exp Immunol 2010;159:23-44
18. Krogvold L, Edwin B, Buanes T, et al. Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: Experiences from the DiViD study. Diabetologia 2014;57:841-843
19. Krogvold L, Wiberg A, Edwin B, et al. Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes. Diabetologia 2016;59:492-501
20. Krogvold L, Skog O, Sundström G, et al. Function of isolated pancreatic islets from patients at onset of type 1 diabetes: Insulin secretion can be restored after some days in a nondiabetogenic environment in vitro: Results from the DiViD Study. Diabetes 2015;64:2506-2512
21. Krogvold L, Edwin B, Buanes T, et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 2015;64:1682-1687
22. Skog O, Ingvast S, Korsgren O. Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and islets of Langerhans. J Clin Virol 2014;61:242-247
23. Berg AK, Korsgren O, Frisk G. Induction of the chemokine interferongamma-inducible protein-10 in human pancreatic islets during enterovirus infection. Diabetologia 2006;49:2697-2703
24. Schulthess FT, Paroni F, Sauter NS, et al. CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab 2009;9:125-139
25. Olsson A, Johansson U, Korsgren O, Frisk G. Inflammatory gene expression in Coxsackievirus B-4-infected human islets of Langerhans. Biochem Biophys Res Commun 2005;330:571-576
26. Schulte BM, Lanke KH, Piganelli JD, et al. Cytokine and chemokine production by human pancreatic islets upon enterovirus infection. Diabetes 2012;61: 2030-2036
27. Weinländer K, Naschberger E, Lehmann MH, et al. Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression. FASEB J 2008;22:4168-4178
28. Hammon M, Herrmann M, Bleiziffer O, et al. Role of guanylate binding protein-1 in vascular defects associated with chronic inflammatory diseases. J Cell Mol Med 2011;15:1582-1592
29. Anagandula M, Richardson SJ, Oberste MS, et al. Infection of human islets of Langerhans with two strains of Coxsackie B virus serotype 1: Assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J Med Virol 2014;86:1402-1411
30. Lind K, Hühn MH, Flodström-Tullberg M. Immunology in the clinic review series; focus on type 1 diabetes and viruses: The innate immune response to enteroviruses and its possible role in regulating type 1 diabetes. Clin Exp Immunol 2012;168:30-38
31. Flodström M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N. Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 2002;3:373-382
32. Izumi K, Mine K, Inoue Y, et al. Reduced Tyk2 gene expression in β-Cells due to natural mutation determines susceptibility to virus-induced diabetes. Nat Commun 2015;6:6748
33. Skog O, Korsgren O, Frisk G. Modulation of innate immunity in human pancreatic islets infected with enterovirus in vitro. J Med Virol 2011;83:658-664
34. Reddy S, Zeng N, Al-Diery H, et al. Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients. Diabetologia 2015; 58:1024-1035